Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional)

The purpose of this NOFO is to support and facilitate multidisciplinary research approaches for the development or improvement of technologies – including drugs, devices, products, or clinical practices – designed to improve fertility outcomes in patients dealing with infertility, particularly in the context of assisted reproductive technologies (ART). This NOFO aims to position innovative and validated technologies for future clinical development.

Posted 9/23/25. Expires 11/21/25.

Read the full article at: https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-26-001.html